Tolerance to cadmium-induced hepatotoxicity following cadmium pretreatment.
Tolerance to several toxic effects of Cd, including lethality, has been shown following pretreatment with Cd. This study was designed to determine if tolerance also develops to Cd-induced hepatotoxicity. Rats were challenged with Cd (2.0, 3.0, 4.0, or 5.0 mg/kg, iv) 24 hr after pretreatment with saline (2 ml/kg, sc) or Cd (2.0 mg/kg, sc). Ten hours following challenge, plasma enzyme activities were dramatically elevated in control rats (sorbitol dehydrogenase 30- to 300-fold and aspartate aminotransferase 3- to 40-fold). In addition, histologic examination revealed moderate to severe hepatic injury, evidenced by cell swelling, cytoplasmic eosinophilia, pyknosis, karyorrhexis, and necrosis. In Cd-pretreated rats, plasma enzyme levels were similar to control values and only slight morphologic changes were evident. This tolerance to Cd-induced hepatotoxicity is probably due to the increase in hepatic metallothionein induced by Cd pretreatment, which has been shown to alter the hepatic subcellular distribution of Cd such that less binds to subcellular organelles and more binds to metallothionein located in the cytosol.
D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood / Q000378:metabolism; D002104:Cadmium / Q000008:administration & dosage / Q000378:metabolism / Q000633:toxicity*; D004361:Drug Tolerance; D007064:L-Iditol 2-Dehydrogenase / Q000097:blood / Q000378:metabolism; D008099:Liver / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains
D002104:Cadmium; D007064:L-Iditol 2-Dehydrogenase; D001219:Aspartate Aminotransferases